Memphis Pharmaceutical turns to profit

In 2018/2019, the company incurred a net loss of $1.58mln in the prior-year period


Egypt - Memphis Pharmaceutical posted a net profit of EGP 15 million for the fiscal year (FY) 2019/2020, according to the company's June 28th statement filed to the Egyptian Exchange.

In FY 2018/2019, the company incurred a net loss of EGP 25.38 million in the prior-year period.

The company posted a net profit of EGP EGP 3.34 million in H1 of the Fiscal Year 2019/2020, versus losses of EGP 18.057 million in the same period a year earlier.

Memphis Company is one of the companies of the drug holding company in Egypt. Memphis Company is considered one of the oldest pharmaceutical and chemical companies in the Middle East since 1940.

Copyright © 2020 Arab Finance Brokerage Company All rights reserved. Provided by SyndiGate Media Inc. (

Disclaimer: The content of this article is syndicated or provided to this website from an external third party provider. We are not responsible for, and do not control, such external websites, entities, applications or media publishers. The body of the text is provided on an “as is” and “as available” basis and has not been edited in any way. Neither we nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this article. Read our full disclaimer policy here.

More From Equities